Nifty's short-term trend has turned bearish, with the next support seen in the 24,900-25,000 range. On the upside, the former ...

As a major South Asian economy with a population of approximately 1.4 billion, India sees significant opportunity for deeper ...

The US Food and Drug Administration (FDA) last week authorized KalVista Pharmaceutical’s Ekterly for the treatment of acute ...

Given the bearish bias in momentum indicators and the weak technical structure, the Nifty 50 is likely to fall toward the ...

Indian markets closed lower for the second straight week, dragged by weak earnings, US tariff threats, and global uncertainty. IT stocks underperformed while Glenmark Pharma led in turnover. Analysts ...

A study found that tumours can impair blood vessel function in muscles, leading to severe muscle weakness in cancer patients.

The next week starting from July 14 is expected to see more consolidation and volatility given the uncertainty around trade ...

Pfizer has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control ...